Patents by Inventor Tina Jung

Tina Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID COMPOSITIONS
    Publication number: 20140171481
    Abstract: The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.
    Type: Application
    Filed: February 14, 2014
    Publication date: June 19, 2014
    Inventors: Bernd Liepold, Tina Jung, Peter H?lig, Rudolf Schroeder, Nancy E. Sever, Justin S. Lafountaine, Brent D. Sinclair, Yi Gao, Jianwei Wu
  • Solid compositions
    Patent number: 8686026
    Abstract: The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: April 1, 2014
    Assignee: AbbVie Inc.
    Inventors: Bernd Liepold, Tina Jung, Peter Hölig, Rudolf Schroeder, Nancy E. Sever, Justin S. Lafountaine, Brent D. Sinclair, Yi Gao, Jianwei Wu
  • Solid Compositions
    Publication number: 20120258909
    Abstract: The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.
    Type: Application
    Filed: June 9, 2011
    Publication date: October 11, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Bernd Liepold, Tina Jung, Peter Hölig, Rudolf Schroeder, Nancy E. Sever, Justin S. Lafountaine, Brent D. Sinclair, Yi Gao, Jianwei Wu
  • PHARMACEUTICAL DOSAGE FORM COMPRISING A LIQUID OR FLOWABLE CORE COMPOSITION
    Publication number: 20100297223
    Abstract: A pharmaceutical dosage form, comprising a) a liquid or flowable core, b) a shell of a polysaccharide or proteinaceous material completely enclosing said core, the core comprising an active ingredient dissolved in a pharmaceutically acceptable compound of the formula (I) wherein n is an integer from 3 to 5, and wherein the (i) the at least one active ingredient and the compound of the formula (I) account for at least 50% by weight of the composition; and (ii) the water activity aw of the composition is less than 0.4.
    Type: Application
    Filed: December 18, 2008
    Publication date: November 25, 2010
    Applicant: ABBOTT GMBH & CO. KG
    Inventors: Jörg Rosenberg, Markus Mägerlein, Jörg Breitenbach, Tina Jung, Ulrich Westedt
  • SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
    Publication number: 20080181948
    Abstract: The present invention features solid pharmaceutical dosage formulations comprising ritonavir. As a non-limiting example, a dosage form of the present invention comprises a solid dispersion or solid solution of ritonavir in a matrix, where the matrix comprises at least one water-soluble polymer, such as copovidone, and at least one surfactant, such as polyoxyl 40 hydrogenated castor oil or macrogolglycerol hydroxystearate. Preferably, the solid dispersion or solution does not include, or includes only an insignificant amount of, PEG.
    Type: Application
    Filed: November 14, 2007
    Publication date: July 31, 2008
    Applicant: Abbott Laboratories
    Inventors: Gunther Berndl, Joerg Rosenberg, Bernd Liepold, Katja Fastnacht, Tina Jung, Wolfgang Roth, Joerg Breitenbach, John Morris, Cheri E. Klein, Yan Cai, Laman Alani, Soumojeet Ghosh